Traumatic brain injury, chronic traumatic encephalopathy, and alzheimer's disease: Common pathologies potentiated by altered zinc homeostasis

Journal of Alzheimer's Disease

Volumn 46, Issue 2, 2015, Pages 297-311

  Portbury, Stuart D ^a   Adlard, Paul A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; amyloid ; brain injury; cognition; tau protein; TDP 43; zinc

Indexed keywords

AMYLOID BETA PROTEIN; TAR DNA BINDING PROTEIN; TAU PROTEIN; ZINC ION; DNA BINDING PROTEIN; TDP-43 PROTEIN, HUMAN; ZINC;

ALZHEIMER DISEASE; AMNESIA; BEHAVIOR DISORDER; BRAIN CONTUSION; BRAIN FUNCTION; BRAIN HEMATOMA; CELL DEATH; CHRONIC BRAIN DISEASE; COGNITION; DIFFUSE AXONAL INJURY; EXCITOTOXICITY; EXECUTIVE FUNCTION; INJURY SEVERITY; LONG TERM POTENTIATION; MEMORY DISORDER; NONHUMAN; OXIDATIVE STRESS; PAIRED HELICAL FILAMENT; PATHOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUALITY OF LIFE; REVIEW; SUBDURAL HEMATOMA; THINKING IMPAIRMENT; TRAFFIC ACCIDENT; TRANSACTIVATION; TRAUMATIC BRAIN INJURY; ZINC HOMEOSTASIS; ANIMAL; BRAIN CHEMISTRY; BRAIN INJURY; COGNITIVE DEFECT; DEFICIENCY; HOMEOSTASIS; HUMAN; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN CHEMISTRY; BRAIN INJURIES; BRAIN INJURY, CHRONIC; COGNITION DISORDERS; DNA-BINDING PROTEINS; HOMEOSTASIS; HUMANS; MEMORY DISORDERS; MICE; OXIDATIVE STRESS; TAU PROTEINS; ZINC;

EID: 84930449296     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-143048     Document Type: Review

References (187)

1. Gavett BE, Stern RA, Cantu RC, Nowinski CJ, McKee AC (2010) Mild traumatic brain injury: A risk factor for neurodegeneration. Alzheimers Res Ther 2, 18
2. Frederickson CJ, Cuajungco MP, Frederickson CJ. 2005 Is zinc the link between compromises of brain perfusion (excitotoxicity) and Alzheimer's disease?. J Alzheimers Dis 8, 155-160
3. Craddock TJ, Tuszynski JA, Chopra D, Casey N, Goldstein LE, Hameroff SR, TanziRE(2012) The zinc dyshomeostasis hypothesis of Alzheimer's disease. PLoS One 7, e33552
4. Tanzi RE, BertramL(2005)Twenty years of the Alzheimer's disease amyloid hypothesis: Agenetic perspective. Cell 120, 545-555
5. Selkoe DJ (2008) Soluble oligomers of the amyloid betaprotein impair synaptic plasticity and behavior. Behav Brain Res 192, 106-113
6. ShankarGM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837-842
7. Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa M, Avila J, Jones PK, Castellani RJ, Smith MA, Perry G (2003) Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol 162, 1623-1627
8. Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC (2007) The impact of traumatic brain injuries: A global perspective. NeuroRehabilitation 22, 341-353
9. Faul M, Xu L, WaldMM, CoronadoV, DellingerAM(2010) Traumatic brain injury in the United States: National estimates of prevalence and incidence, 2002-2006. Inj Prev 16, A268
10. Corsellis JA, Bruton CJ, Freeman-Browne D (1973) The aftermath of boxing. Psychol Med 3, 270-303
11. Guskiewicz KM, Marshall SW, Bailes J, McCrea M, Cantu RC, Randolph C, Jordan BD (2005) Association between recurrent concussion and late-life cognitive impairment in retired professional football players. Neurosurgery 57, 719-726; discussion 719-726
12. Omalu B, Bailes J, Hamilton RL, Kamboh MI, Hammers J, Case M, Fitzsimmons R (2011) Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes. Neurosurgery 69, 173-183; discussion 183
13. Omalu BI, Bailes J, Hammers JL, Fitzsimmons RP (2010) Chronic traumatic encephalopathy, suicides and parasuicides in professional American athletes: The role of the forensic pathologist.AmJ Forensic Med Pathol 31, 130-132
14. Omalu BI, Hamilton RL, Kamboh MI, DeKosky ST, Bailes J (2010) Chronic traumatic encephalopathy (CTE) in a National Football League Player: Case report and emerging medicolegal practice questions. J Forensic Nurs 6, 40-46
15. Goldstein LE, Fisher AM, Tagge CA, Zhang XL, Velisek L, Sullivan JA, Upreti C, Kracht JM, Ericsson M, Wojnarowicz MW, Goletiani CJ, Maglakelidze GM, Casey N, Moncaster JA, Minaeva O, Moir RD, Nowinski CJ, Stern RA, Cantu RC, Geiling J, Blusztajn JK, Wolozin BL, Ikezu T, Stein TD, Budson AE, Kowall NW, Chargin D, Sharon A, Saman S, Hall GF, Moss WC, Cleveland RO, Tanzi RE, Stanton PK, McKee AC (2012) Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med 4, 134ra160
16. McIntosh TK, Saatman KE, Raghupathi R, Graham DI, Smith DH, Lee VM, Trojanowski JQ (1998) The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: Pathogenetic mechanisms. Neuropathol Appl Neurobiol 24, 251-267
17. Kotapka MJ, Graham DI, Adams JH, Gennarelli TA (1994) Hippocampal pathology in fatal human head injury without high intracranial pressure. J Neurotrauma 11, 317-324
18. Molgaard CA, Stanford EP, Morton DJ, Ryden LA, Schubert KR, Golbeck AL (1990) Epidemiology of head trauma and neurocognitive impairment in a multi-ethnic population. Neuroepidemiology 9, 233-242
19. Mortimer JA, French LR, Hutton JT, Schuman LM (1985) Head injury as a risk factor for Alzheimer's disease. Neurology 35, 264-267
20. MortimerJA, vanDuijnCM, ChandraV, FratiglioniL, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, RoccaWA, Shalat SL, Soininen H, Hofman A (1991) Head trauma as a risk factor for Alzheimer's disease: A collaborative reanalysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20(Suppl 2), S28-S35
21. Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB, Raskind M (1990) The association between head trauma and Alzheimer's disease. Am J Epidemiol 131, 491-501
22. O'Meara ES, Kukull WA, Sheppard L, Bowen JD, McCormick WC, Teri L, Pfanschmidt M, Thompson JD, Schellenberg GD, Larson EB (1997) Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. Am J Epidemiol 146, 373-384
23. Salib E, Hillier V (1997) Head injury and the risk of Alzheimer's disease: A case control study. Int J Geriatr Psychiatry 12, 363-368
24. SchofieldPW, Tang M, Marder K, Bell K, Dooneief G, Chun M, Sano M, Stern Y, Mayeux R (1997) Alzheimer's disease after remote head injury: An incidence study. J Neurol Neurosurg Psychiatry 62, 119-124
25. Sullivan P, Petitti D, Barbaccia J (1987) Head trauma and age of onset of dementia of the Alzheimer type. JAMA 257, 2289-2290
26. Gedye A, Beattie BL, Tuokko H, Horton A, Korsarek E (1989) Severe head injury hastens age of onset of Alzheimer's disease. J Am Geriatr Soc 37, 970-973
27. Nemetz PN, Leibson C, Naessens JM, Beard M, Kokmen E, Annegers JF, Kurland LT (1999) Traumatic brain injury and time to onset of Alzheimer's disease: A population-based study. Am J Epidemiol 149, 32-40
28. Guo Z, Cupples LA, Kurz A, Auerbach SH, Volicer L, Chui H, Green RC, Sadovnick AD, Duara R, DeCarli C, Johnson K, Go RC, Growdon JH, Haines JL, KukullWA, Farrer LA (2000) Head injury and the risk ofADin theMIRAGEstudy. Neurology 54, 1316-1323
29. Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick D, Phillips C, Gau BA, Welsh-Bohmer KA, Burke JR, Guralnik JM, Breitner JC (2000) Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55, 1158-1166
30. Marklund N, Farrokhnia N, Hanell A, Vanmechelen E, Enblad P, ZetterbergH, BlennowK, Hillered L (2014) Monitoring of beta-Amyloid dynamics after human traumatic brain injury. J Neurotrauma 31, 42-55
31. Nordstrom P, Michaelsson K, Gustafson Y, Nordstrom A (2014) Traumatic brain injury and young onset dementia: A nationwide cohort study. Ann Neurol 75, 374-381
32. Gilbert M, Snyder C, Corcoran C, Norton MC, Lyketsos CG, Tschanz JT (2014) The association of traumatic brain injury with rate of progression of cognitive and functional impairment in a population-based cohort of Alzheimer's disease: The Cache County Dementia Progression Study. Int Psychogeriatr 26, 1593-1601
33. Chandra V, Philipose V, Bell PA, Lazaroff A, Schoenberg BS (1987) Case-control study of late onset "probable Alzheimer's disease". Neurology 37, 1295-1300
34. Amaducci LA, Fratiglioni L, Rocca WA, Fieschi C, Livrea P, Pedone D, Bracco L, Lippi A, Gandolfo C, Bino G, et al. (1986) Risk factors for clinically diagnosed Alzheimer's disease: A case-control study of an Italian population. Neurology 36, 922-931
35. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, JormAF, LongleyW, Anthony JC(1990)Acase-control study of Alzheimer's disease in Australia. Neurology 40, 1698-1707
36. Ferini-Strambi L, Smirne S, Garancini P, Pinto P, Franceschi M (1990) Clinical and epidemiological aspects of Alzheimer's disease with presenile onset: A case control study. Neuroepidemiology 9, 39-49
37. Katzman R, Aronson M, Fuld P, Kawas C, Brown T, Morgenstern H, Frishman W, Gidez L, Eder H, Ooi WL (1989) Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 25, 317-324
38. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A (1999) Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEMpooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 52, 78-84
39. Mehta KM, Ott A, Kalmijn S, Slooter AJ, van Duijn CM, Hofman A, Breteler MM (1999) Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study. Neurology 53, 1959-1962
40. Williams DB, Annegers JF, Kokmen E, O'Brien PC, Kurland LT (1991) Brain injury and neurologic sequelae: A cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis. Neurology 41, 1554-1557
41. Kawai N, Kawanishi M, Kudomi N, Maeda Y, Yamamoto Y, Nishiyama Y, Tamiya T (2013) Detection of brain amyloid beta deposition in patients with neuropsychological impairment after traumatic brain injury: PET evaluation using Pittsburgh Compound-B. Brain Inj 27, 1026-1031
42. Dams-O'Connor K, Spielman L, Hammond FM, Sayed N, Culver C, Diaz-Arrastia R (2013) An exploration of clinical dementia phenotypes among individuals with and without traumatic brain injury. NeuroRehabilitation 32, 199-209
43. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923
44. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472
45. Teasdale GM, Nicoll JA, Murray G, FiddesM(1997) Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350, 1069-1071
46. Sorbi S, Nacmias B, Piacentini S, Repice A, Latorraca S, Forleo P, Amaducci L (1995) ApoE as a prognostic factor for post-traumatic coma. Nat Med 1, 852
47. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, Babaey S, Yehuda B, Groswasser Z (1999) Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 52, 244-248
48. Liberman JN, Stewart WF, Wesnes K, Troncoso J (2002) Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injury. Neurology 58, 1038-1044
49. Sundstrom A, Marklund P, Nilsson LG, Cruts M, Adolfsson R, Van Broeckhoven C, Nyberg L (2004) APOE influences on neuropsychological function after mild head injury: Within-person comparisons. Neurology 62, 1963-1966
50. Lichtman SW, Seliger G, Tycko B, Marder K (2000) Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology 55, 1536-1539
51. Liaquat I, Dunn LT, Nicoll JA, Teasdale GM, Norrie JD (2002) Effect of apolipoprotein E genotype on hematoma volume after trauma. J Neurosurg 96, 90-96
52. Smith C, Graham DI, Murray LS, Stewart J, Nicoll JA(2006) Association of APOE e4 and cerebrovascular pathology in traumatic brain injury. J Neurol Neurosurg Psychiatry 77, 363-366
53. Diaz-Arrastia R, Gong Y, Fair S, Scott KD, Garcia MC, Carlile MC, Agostini MA, Van Ness PC (2003) Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurol 60, 818-822
54. Roberts GW, Gentleman SM, Lynch A, Graham DI (1991) beta A4 amyloid protein deposition in brain after head trauma. Lancet 338, 1422-1423
55. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI (1994) Beta amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 57, 419-425
56. Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VM, Clark RS, Marion DW, Wisniewski SR, DeKosky ST (2004) Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 190, 192-203
57. DeKosky ST, Abrahamson EE, Ciallella JR, Paljug WR, Wisniewski SR, Clark RS, Ikonomovic MD (2007) Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch Neurol 64, 541-544
58. Gentleman SM, Greenberg BD, Savage MJ, Noori M, Newman SJ, RobertsGW, Griffin WS, Graham DI (1997) A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. Neuroreport 8, 1519-1522
59. Hong YT, Veenith T, Dewar D, Outtrim JG, Mani V, Williams C, Pimlott S, Hutchinson PJ, Tavares A, Canales R, Mathis CA, Klunk WE, Aigbirhio FI, Coles JP, Baron JC, Pickard JD, Fryer TD, StewartW, Menon DK (2013) Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury. JAMA Neurol 71, 23-31
60. McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, Santini VE, Lee HS, Kubilus CA, Stern RA (2009) Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 68, 709-735
61. Mann DM, Brown AM, Prinja D, Jones D, Davies CA (1990) A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. Neuropathol Appl Neurobiol 16, 17-25
62. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754
63. Lewen A, Li GL, Nilsson P, Olsson Y, Hillered L (1995) Traumatic brain injury in rat produces changes of betaamyloid precursor protein immunoreactivity. Neuroreport 6, 357-360
64. Pierce JE, Trojanowski JQ, Graham DI, Smith DH, McIntosh TK (1996) Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-Amyloid peptide after experimental brain injury in the rat. J Neurosci 16, 1083-1090
65. Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 5, 421-432
66. Murai H, Pierce JE, Raghupathi R, Smith DH, Saatman KE, Trojanowski JQ, Lee VM, Loring JF, Eckman C, Younkin S, McIntosh TK (1998) Twofold overexpression of human beta-Amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury. J Comp Neurol 392, 428-438
67. Smith DH, Nakamura M, McIntosh TK, Wang J, Rodriguez A, Chen XH, Raghupathi R, Saatman KE, Clemens J, Schmidt ML, Lee VM, Trojanowski JQ (1998) Brain trauma induces massive hippocampal neuron death linked to a surge in beta-Amyloid levels in mice overexpressing mutant amyloid precursor protein. Am J Pathol 153, 1005-1010
68. Tajiri N, Kellogg SL, Shimizu T, Arendash GW, Borlongan CV (2013) Traumatic brain injury precipitates cognitive impairment and extracellular Abeta aggregation in Alzheimer's disease transgenic mice. PLoS One 8, e78851
69. Washington PM, Morffy N, Parsadanian M, Zapple DN, Burns MP (2014) Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloidbeta in an Alzheimer's disease mouse model. J Neurotrauma 31, 125-134
70. Albert-Weissenberger C, Siren AL (2010) Experimental traumatic brain injury. Exp Transl Stroke Med 2, 16
71. O'Connor WT, Smyth A, Gilchrist MD (2011) Animal models of traumatic brain injury: Acritical evaluation. Pharmacol Ther 130, 106-113
72. Johnson VE, Stewart W, Smith DH (2012) Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol 22, 142-149
73. Smith DH, Chen XH, Xu BN, McIntosh TK, Gennarelli TA, Meaney DF (1997) Characterization of diffuse axonal pathology and selective hippocampal damage following inertial brain trauma in the pig. J Neuropathol Exp Neurol 56, 822-834
74. MeaneyDF, SmithDH, ShreiberDI, BainAC, MillerRT, Ross DT, Gennarelli TA(1995) Biomechanical analysis of experimental diffuse axonal injury. J Neurotrauma 12, 689-694
75. Smith DH, Chen XH, Nonaka M, Trojanowski JQ, Lee VM, Saatman KE, Leoni MJ, Xu BN, Wolf JA, MeaneyDF (1999) Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J Neuropathol Exp Neurol 58, 982-992
76. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-Amyloid precursor protein. Neuron 10, 243-254
77. Milward EA, Papadopoulos R, Fuller SJ, Moir RD, Small D, Beyreuther K, Masters CL (1992) The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nervegrowthfactoronneuriteoutgrowth.Neuron9, 129-137
78. Roch JM, Jin LW, Ninomiya H, Schubert D, Saitoh T (1993) Biologically active domain of the secreted form of the amyloid beta/A4 protein precursor. Ann N Y Acad Sci 695, 149-157
79. Small DH, Clarris HL, Williamson TG, Reed G, Key B, Mok SS, Beyreuther K, Masters CL, Nurcombe V (1999) Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease. J Alzheimers Dis 1, 275-285
80. Small DH, Nurcombe V, Reed G, Clarris H, Moir R, Beyreuther K, Masters CL (1994) A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J Neurosci 14, 2117-2127
81. Morimoto T, Ohsawa I, Takamura C, Ishiguro M, Kohsaka S (1998) Involvement of amyloid precursor protein in functional synapse formation in cultured hippocampal neurons. J Neurosci Res 51, 185-195
82. Van den Heuvel C, Blumbergs PC, Finnie JW, Manavis J, Jones NR, Reilly PL, Pereira RA (1999) Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: An ovine head impact model. Exp Neurol 159, 441-450
83. Thornton E, Vink R, Blumbergs PC, Van Den Heuvel C (2006) Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res 1094, 38-46
84. Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C (2012) sAPPalpha rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury. J Neurochem 122, 208-220
85. McKenzie JE, Gentleman SM, Roberts GW, Graham DI, Royston MC (1994) Increased numbers of beta APPimmunoreactive neurones in the entorhinal cortex after head injury. Neuroreport 6, 161-164
86. Sherriff FE, Bridges LR, Sivaloganathan S (1994) Early detection of axonal injury after human head trauma using immunocytochemistry for beta-Amyloid precursor protein. Acta Neuropathol 87, 55-62
87. Gentleman SM, Roberts GW, Gennarelli TA, Maxwell WL, Adams JH, Kerr S, Graham DI (1995) Axonal injury: A universal consequence of fatal closed head injury?. Acta Neuropathol 89, 537-543
88. Ahlgren S, Li GL, Olsson Y (1996) Accumulation of betaamyloid precursor protein and ubiquitin in axons after spinal cord trauma in humans: Immunohistochemical observations on autopsy material. Acta Neuropathol 92, 49-55
89. Gleckman AM, Bell MD, Evans RJ, Smith TW (1999) Diffuse axonal injury in infants with nonaccidental craniocerebral trauma: Enhanced detection by beta-Amyloid precursor protein immunohistochemical staining. Arch Pathol Lab Med 123, 146-151
90. Smith DH, Chen XH, Iwata A, Graham DI (2003) Amyloid beta accumulation in axons after traumatic brain injury in humans. J Neurosurg 98, 1072-1077
91. Uryu K, Chen XH, Martinez D, Browne KD, Johnson VE, Graham DI, Lee VM, Trojanowski JQ, Smith DH (2007) Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp Neurol 208, 185-192
92. Chen XH, Johnson VE, Uryu K, Trojanowski JQ, Smith DH (2009) A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol 19, 214-223
93. Graham DI, Gentleman SM, Lynch A, Roberts GW (1995) Distribution of beta-Amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol 21, 27-34
94. Horsburgh K, Cole GM, Yang F, Savage MJ, Greenberg BD, Gentleman SM, Graham DI, Nicoll JA (2000) beta-Amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury. Neuropathol Appl Neurobiol 26, 124-132
95. Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2, a006247
96. Dale GE, Leigh PN, Luthert P, Anderton BH, Roberts GW (1991) Neurofibrillary tangles in dementia pugilistica are ubiquitinated. J Neurol Neurosurg Psychiatry 54, 116-118
97. Hof PR, Bouras C, Buee L, Delacourte A, Perl DP, Morrison JH (1992) Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol 85, 23-30
98. Schmidt ML, Zhukareva V, Newell KL, Lee VM, Trojanowski JQ (2001) Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol 101, 518-524
99. Tokuda T, Ikeda S, Yanagisawa N, Ihara Y, Glenner GG (1991) Re-examination of ex-boxers brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein. Acta Neuropathol 82, 280-285
100. Tran HT, LaFerla FM, Holtzman DM, Brody DL (2011) Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-Axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities. J Neurosci 31, 9513-9525
101. Ojo JO, Mouzon B, Greenberg MB, Bachmeier C, Mullan M, Crawford F (2013) Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice. J Neuropathol Exp Neurol 72, 137-151
102. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, ClarkCM, McCluskeyLF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133
103. Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K (2009) Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: Their relation to AD common pathology. Neuropathology 29, 566-573
104. King A, Sweeney F, Bodi I, Troakes C, Maekawa S, Al-Sarraj S (2010) Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease. Neuropathology 30, 408-419
105. McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, Perl DP, Hedley-Whyte ET, Price B, Sullivan C, Morin P, Lee HS, Kubilus CA, Daneshvar DH, Wulff M, BudsonAE(2010) TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 69, 918-929
106. Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67, 555-564
107. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61, 435-445
108. Lippa CF, Rosso AL, Stutzbach LD, Neumann M, Lee VM, Trojanowski JQ (2009) Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome. Arch Neurol 66, 1483-1488
109. Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, Baker M, Rademakers R, Boeve BF, Parisi JE, Smith GE, Ivnik RJ, Petersen RC, Jack CR Jr, Dickson DW (2008) Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70, 1850-1857
110. Lynch MA (2004) Long-term potentiation and memory. Physiol Rev 84, 87-136
111. Tsai KJ, Yang CH, Fang YH, Cho KH, Chien WL, Wang WT, Wu TW, Lin CP, Fu WM, Shen CK (2010) Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J Exp Med 207, 1661-1673
112. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356
113. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1, 213-216
114. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 27, 457-464
115. Francis PT (2003) Glutamatergic systems in Alzheimer's disease. Int J Geriatr Psychiatry 18, S15-S21
116. Klyubin I, Wang Q, Reed MN, Irving EA, Upton N, Hofmeister J, Cleary JP, Anwyl R, Rowan MJ (2011) Protection against Abeta-mediated rapid disruption of synaptic plasticity and memory by memantine. Neurobiol Aging 32, 614-623
117. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D (2009) Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788-801
118. Boekhoorn K, Terwel D, Biemans B, Borghgraef P, Wiegert O, Ramakers GJ, de Vos K, Krugers H, Tomiyama T, Mori H, Joels M, van Leuven F, Lucassen PJ (2006) Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neurosci 26, 3514-3523
119. Ondrejcak T, Klyubin I, Hu NW, Barry AE, Cullen WK, RowanMJ (2010) Alzheimer's disease amyloid beta-protein and synaptic function. Neuromolecular Med 12, 13-26
120. Lehman EJ, Hein MJ, Baron SL, Gersic CM (2012) Neurodegenerative causes of death among retired National Football League players. Neurology 79, 1970-1974
121. Mouzon B, Chaytow H, Crynen G, Bachmeier C, Stewart J, Mullan M, Stewart W, Crawford F (2012) Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes. J Neurotrauma 29, 2761-2773
122. Bush AI, PettingellWH, Multhaup G, d Paradis M, Vonsattel JP, Gusella JF, Beyreuther K, Masters CL, Tanzi RE (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265, 1464-1467
123. Caragounis A, Price KA, Soon CP, Filiz G, Masters CL, Li QX, Crouch PJ, White AR (2010) Zinc induces depletion and aggregation of endogenous TDP-43. Free Radic Biol Med 48, 1152-1161
124. An WL, Bjorkdahl C, Liu R, Cowburn RF, Winblad B, Pei JJ (2005) Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells. J Neurochem 92, 1104-1115
125. Pan E, Zhang XA, Huang Z, Krezel A, Zhao M, Tinberg CE, Lippard SJ, McNamara JO (2011) Vesicular zinc promotes presynaptic and inhibits postsynaptic long-term potentiation of mossy fiber-CA3 synapse. Neuron 71, 1116-1126
126. Szewczyk B (2013) Zinc homeostasis and neurodegenerative disorders. Front Aging Neurosci 5, 33
127. Sensi SL, Paoletti P, Koh JY, Aizenman E, Bush AI, Hershfinkel M (2011) The neurophysiology and pathology of brain zinc. J Neurosci 31, 16076-16085
128. Perez-Clausell J, Danscher G (1985) Intravesicular localization of zinc in rat telencephalic boutons. A histochemical study. Brain Res 337, 91-98
129. Frederickson CJ, Suh SW, Silva D, Frederickson CJ, Thompson RB (2000) Importance of zinc in the central nervous system: The zinc-containing neuron. J Nutr 130, 1471S-1483S.
130. Takeda A (2001) Zinc homeostasis and functions of zinc in the brain. Biometals 14, 343-351
131. Wei G, Hough CJ, Li Y, Sarvey JM (2004) Characterization of extracellular accumulation of Zn2+ during ischemia and reperfusion of hippocampus slices in rat. Neuroscience 125, 867-877
132. Danscher G, Stoltenberg M (2005) Zinc-specific autometallographic in vivo selenium methods: Tracing of zinc-enriched (ZEN) terminals, ZEN pathways, and pools of zinc ions in a multitude of other ZEN cells. J Histochem Cytochem 53, 141-153
133. Danscher G, Jo SM, Varea E, Wang Z, Cole TB, Schroder HD (2001) Inhibitory zinc-enriched terminals in mouse spinal cord. Neuroscience 105, 941-947
134. Wang Z, Danscher G, Kim YK, Dahlstrom A, Mook Jo S (2002) Inhibitory zinc-enriched terminals in the mouse cerebellum: Double-immunohistochemistry for zinc transporter 3 and glutamate decarboxylase. Neurosci Lett 321, 37-40
135. Paoletti P, Vergnano AM, Barbour B, CasadoM(2009) Zinc at glutamatergic synapses. Neuroscience 158, 126-136
136. Frederickson CJ, Burdette SC, Frederickson CJ, Sensi SL, Weiss JH, Yin HZ, Balaji RV, Truong-Tran AQ, Bedell E, Prough DS, Lippard SJ (2004) Method for identifying neuronal cells suffering zinc toxicity by use of a novel fluorescent sensor. J Neurosci Methods 139, 79-89
137. Mo ZY, Zhu YZ, Zhu HL, Fan JB, Chen J, Liang Y (2009) Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322. J Biol Chem 284, 34648-34657
138. McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, Lee HS, Wojtowicz SM, Hall G, Baugh CM, Riley DO, Kubilus CA, Cormier KA, Jacobs MA, Martin BR, Abraham CR, Ikezu T, Reichard RR, Wolozin BL, Budson AE, Goldstein LE, Kowall NW, Cantu RC (2013) The spectrum of disease in chronic traumatic encephalopathy. Brain 136, 43-64
139. Hardy JA, Higgins GA (1992) Alzheimer's disease: The amyloid cascade hypothesis. Science 256, 184-185
140. Adlard PA, Bush AI (2006) Metals and Alzheimer's disease. J Alzheimers Dis 10, 145-163
141. Bush AI, Pettingell WH Jr, Paradis MD, Tanzi RE (1994) Modulation of A beta adhesiveness and secretase site cleavage by zinc. J Biol Chem 269, 12152-12158
142. Garai K, Sahoo B, Kaushalya SK, Desai R, Maiti S (2007) Zinc lowers amyloid-beta toxicity by selectively precipitating aggregation intermediates. Biochemistry 46, 10655-10663
143. Noy D, Solomonov I, Sinkevich O, Arad T, Kjaer K, Sagi I (2008) Zinc-Amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species. J Am Chem Soc 130, 1376-1383
144. Yang DS, McLaurin J, Qin K, WestawayD, Fraser PE (2000) Examining the zinc binding site of the amyloid-beta peptide. Eur J Biochem 267, 6692-6698
145. Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J (2006) Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn colocalized with beta-Amyloid deposits in Alzheimer's disease. J Struct Biol 155, 30-37
146. Adlard PA, Parncutt JM, Finkelstein DI, Bush AI (2010) Cognitive loss in zinc transporter-3 knock-out mice: A phenocopy for the synaptic and memory deficits of Alzheimer's disease?. J Neurosci 30, 1631-1636
147. Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY (2002) Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A 99, 7705-7710
148. Friedlich AL, Lee JY, van Groen T, Cherny RA, Volitakis I, Cole TB, Palmiter RD, Koh JY, Bush AI (2004) Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. J Neurosci 24, 3453-3459
149. Deshpande A, Kawai H, Metherate R, Glabe CG, Busciglio J (2009) A role for synaptic zinc in activity-dependent a beta oligomer formation and accumulation at excitatory synapses. J Neurosci 29, 4004-4015
150. Li F, Tsien JZ (2009) Memory and the NMDA receptors. N Engl J Med 361, 302-303
151. Frederickson CJ, MaretW, Cuajungco MP (2004) Zinc and excitotoxic brain injury: A new model. Neuroscientist 10, 18-25
152. Faden AI, Demediuk P, Panter SS, Vink R (1989) The role of excitatory amino acids andNMDA receptors in traumatic brain injury. Science 244, 798-800
153. Obrenovitch TP, Urenjak J (1997) Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury?. J Neurotrauma 14, 677-698
154. Pei JJ, An WL, ZhouXW, Nishimura T, Norberg J, Benedikz E, Gotz J, Winblad B (2006) P70 S6 kinase mediates tau phosphorylation and synthesis. FEBS Lett 580, 107-114
155. Sun XY, Wei YP, Xiong Y, Wang XC, Xie AJ, Wang XL, Yang Y, Wang Q, Lu YM, Liu R, Wang JZ (2012) Synaptic released zinc promotes tau hyperphosphorylation by inhibition of protein phosphatase 2A (PP2A). J Biol Chem 287, 11174-11182
156. Cuajungco MP, Lees GJ (1998) Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya. Brain Res 799, 118-129
157. Frederickson CJ, Cuajungco MP, LaBuda CJ, Suh SW (2002) Nitric oxide causes apparent release of zinc from presynaptic boutons. Neuroscience 115, 471-474
158. Maret W (1994) Oxidative metal release from metallothionein via zinc-thiol/disulfide interchange. Proc Natl Acad Sci U S A 91, 237-241
159. Maret W, Vallee BL (1998) Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci U S A 95, 3478-3482
160. Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin B, Reynolds IJ (2000) Induction of neuronal apoptosis by thiol oxidation: Putative role of intracellular zinc release. J Neurochem 75, 1878-1888
161. Bossy-Wetzel E, Talantova MV, Lee WD, Scholzke MN, Harrop A, Mathews E, Gotz T, Han J, Ellisman MH, Perkins GA, Lipton SA (2004) Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-Activated K+ channels. Neuron 41, 351-365
162. Sensi SL, Ton-That D, Sullivan PG, Jonas EA, Gee KR, Kaczmarek LK, Weiss JH (2003) Modulation of mitochondrial function by endogenous Zn2+ pools. Proc Natl Acad Sci U S A 100, 6157-6162
163. Sensi SL, Rapposelli IG, Frazzini V, Mascetra N (2008) Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease. Exp Gerontol 43, 488-492
164. BlissTV, CollingridgeGL(1993)Asynaptic model of memory: Long-term potentiation in the hippocampus. Nature 361, 31-39
165. Nilsson P, Hillered L, Olsson Y, Sheardown MJ, Hansen AJ (1993) Regional changes in interstitial K+ and Ca2+ levels following cortical compression contusion trauma in rats. J Cereb Blood Flow Metab 13, 183-192
166. Clark RS, Schiding JK, Kaczorowski SL, Marion DW, Kochanek PM (1994) Neutrophil accumulation after traumatic brain injury in rats: Comparison of weight drop and controlled cortical impact models. J Neurotrauma 11, 499-506
167. Bullock R, Zauner A, Myseros JS, Marmarou A, Woodward JJ, Young HF (1995) Evidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical events. Ann N Y Acad Sci 765, 290-297; discussion 298
168. Tonder N, Johansen FF, Frederickson CJ, Zimmer J, Diemer NH(1990) Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat. Neurosci Lett 109, 247-252
169. Frederickson CJ, Hernandez MD, McGinty JF (1989) Translocation of zinc may contribute to seizure-induced death of neurons. Brain Res 480, 317-321
170. Suh SW, Chen JW, Motamedi M, Bell B, Listiak K, Pons NF, Danscher G, Frederickson CJ (2000) Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury. Brain Res 852, 268-273
171. Hellmich HL, Frederickson CJ, DeWitt DS, Saban R, Parsley MO, Stephenson R, Velasco M, Uchida T, Shimamura M, Prough DS (2004) Protective effects of zinc chelation in traumatic brain injury correlate with upregulation of neuroprotective genes in rat brain. Neurosci Lett 355, 221-225
172. Doering P, StoltenbergM, PenkowaM, Rungby J, Larsen A, Danscher G (2010) Chemical blocking of zinc ions in CNS increases neuronal damage following traumatic brain injury (TBI) in mice. PLoS One 5, e10131
173. Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, Choi DW (1996) The role of zinc in selective neuronal death after transient global cerebral ischemia. Science 272, 1013-1016
174. Cuajungco MP, Lees GJ (1996) Prevention of zinc neurotoxicity in vivo by N, N, N-, N-tetrakis (2-pyridylmethyl) ethylene-diamine (TPEN). Neuroreport 7, 1301-1304
175. Cuajungco MP, Lees GJ (1998) Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus. Brain Res 799, 97-107
176. Lees GJ, Cuajungco MP, Leong W (1998) Effect of metal chelating agents on the direct and seizure-related neuronal death induced by zinc and kainic acid. Brain Res 799, 108-117
177. Cope EC, Morris DR, ScrimgeourAG, VanLandingham JW, LevensonCW(2011) Zinc supplementation provides behavioral resiliency in a rat model of traumatic brain injury. Physiol Behav 104, 942-947
178. Cope EC, Morris DR, ScrimgeourAG, LevensonCW(2012) Use of zinc as a treatment for traumatic brain injury in the rat: Effects on cognitive and behavioral outcomes. Neurorehabil Neural Repair 26, 907-913
179. Wensink J, Lenglet WJ, Vis RD, Van den Hamer CJ (1987) The effect of dietary zinc deficiency on the mossy fiber zinc content of the rat hippocampus. A microbeam PIXE study. Particle Induced X-Ray Emission. Histochemistry 87, 65-69
180. Yeiser EC, Vanlandingham JW, Levenson CW (2002) Moderate zinc deficiency increases cell death after brain injury in the rat. Nutr Neurosci 5, 345-352
181. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-Amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676
182. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX, Charman SA, Nicolazzo JA, Wilkins S, Deleva K, Lynch T, Kok G, Ritchie CW, Tanzi RE, Cappai R, Masters CL, Barnham KJ, Bush AI (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59, 43-55
183. Barnham KJ, Bush AI (2014) Biological metals and metaltargeting compounds in major neurodegenerative diseases. Chem Soc Rev 43, 6727-6749
184. Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, Bedo J, Harrison J, Lannfelt L, Blennow K, Zetterberg H, Ingelsson M, Masters CL, Tanzi RE, Cummings JL, Herd CM, Bush AI (2010) PBT2 rapidly improves cognition in Alzheimer's disease: Additional phase II analyses. J Alzheimers Dis 20, 509-516
185. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters CL, Targum S, Bush AI, Murdoch R, Wilson J, RitchieCW, PBT2-201-EUROstudy group (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: A phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol 7, 779-786
186. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: Apilot phase 2 clinical trial. Arch Neurol 60, 1685-1691
187. McClain CJ, Twyman DL, Ott LG, Rapp RP, Tibbs PA, Norton JA, Kasarskis EJ, Dempsey RJ, Young B (1986) Serum and urine zinc response in head-injured patients. J Neurosurg 64, 224-230